1220.4000 -0.30 (-0.02%)
NSE Feb 27, 2026 15:31 PM
Volume: 1.8M
 

1220.40
-0.02%
Phillip Capital
products, price erosion in base business and delay in third party order supply. Guides forhealthygrowthQ4onwardsledbynewlaunches 9 EBITDAaswellasearningperformancewasinlineofexpectations...
ICICI Direct increased Buy price target of Aurobindo Pharma Ltd. to 1425.0 on 15 Feb, 2026.
More from Aurobindo Pharma Ltd.
Recommended